Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1395496

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1395496

Global Alzheimer's Disease Therapeutics Market 2024-2028

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Abstract

The alzheimer's disease therapeutics market is forecasted to grow by USD 5.41 bn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the alzheimer's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability, research, and development of novel biomarkers, increasing awareness of Alzheimers disease, and strong pipeline coupled with approval of therapeutics.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20248.83%
CAGR10.03%
Incremental Value$5.41bn

Technavio's alzheimer's disease therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • E-commerce pharmacy

By Drug Class

  • Cholinesterase inhibitors
  • N-methyl-D-aspartate receptor antagonist
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of regenerative therapies as one of the prime reasons driving the Alzheimer's disease therapeutics market growth during the next few years. Also, increasing funding for therapeutics discovery and availability of highly sensitive diagnostic modalities will lead to sizable demand in the market.

The report on the alzheimer's disease therapeutics market covers the following areas:

  • Alzheimer's disease therapeutics market sizing
  • Alzheimer's disease therapeutics market forecast
  • Alzheimer's disease therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading alzheimer's disease therapeutics market vendors that include AB Science SA, AbbVie Inc., AgeneBio Inc., Biogen Inc., Cipla Ltd., Curasia Medilab, Denali Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Grifols SA, H Lundbeck AS, Johnson and Johnson, Lifecare Neuro Products Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., Psycogen Captab, Solco Healthcare, Teva Pharmaceutical Industries Ltd., and Aurobindo Pharma Ltd.. Also, the alzheimer's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40742

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global alzheimers disease therapeutics market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global alzheimers disease therapeutics market 2018 - 2022 ($ billion)
  • 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • 4.3 Drug class Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Drug class Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.4 Retail pharmacy - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.5 E-commerce pharmacy - Market size and forecast 2023-2028
  • Exhibit 42: Chart on E-commerce pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 43: Data Table on E-commerce pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 44: Chart on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 46: Market opportunity by Distribution Channel ($ billion)
  • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Drug Class

  • 7.1 Market segments
  • Exhibit 48: Chart on Drug Class - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Drug Class - Market share 2023-2028 (%)
  • 7.2 Comparison by Drug Class
  • Exhibit 50: Chart on Comparison by Drug Class
  • Exhibit 51: Data Table on Comparison by Drug Class
  • 7.3 Cholinesterase inhibitors - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 53: Data Table on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 54: Chart on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
  • 7.4 N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028
  • Exhibit 56: Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 57: Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 58: Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023-2028 (%)
  • 7.5 Others - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.6 Market opportunity by Drug Class
  • Exhibit 64: Market opportunity by Drug Class ($ billion)
  • Exhibit 65: Data Table on Market opportunity by Drug Class ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Canada - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
  • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 Japan - Market size and forecast 2023-2028
  • Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 AB Science SA
  • Exhibit 115: AB Science SA - Overview
  • Exhibit 116: AB Science SA - Product / Service
  • Exhibit 117: AB Science SA - Key offerings
  • 12.4 AbbVie Inc.
  • Exhibit 118: AbbVie Inc. - Overview
  • Exhibit 119: AbbVie Inc. - Product / Service
  • Exhibit 120: AbbVie Inc. - Key news
  • Exhibit 121: AbbVie Inc. - Key offerings
  • 12.5 AgeneBio Inc.
  • Exhibit 122: AgeneBio Inc. - Overview
  • Exhibit 123: AgeneBio Inc. - Product / Service
  • Exhibit 124: AgeneBio Inc. - Key offerings
  • 12.6 Aurobindo Pharma Ltd.
  • Exhibit 125: Aurobindo Pharma Ltd. - Overview
  • Exhibit 126: Aurobindo Pharma Ltd. - Product / Service
  • Exhibit 127: Aurobindo Pharma Ltd. - Key offerings
  • 12.7 Cipla Ltd.
  • Exhibit 128: Cipla Ltd. - Overview
  • Exhibit 129: Cipla Ltd. - Business segments
  • Exhibit 130: Cipla Ltd. - Key news
  • Exhibit 131: Cipla Ltd. - Key offerings
  • Exhibit 132: Cipla Ltd. - Segment focus
  • 12.8 Eisai Co. Ltd.
  • Exhibit 133: Eisai Co. Ltd. - Overview
  • Exhibit 134: Eisai Co. Ltd. - Business segments
  • Exhibit 135: Eisai Co. Ltd. - Key offerings
  • Exhibit 136: Eisai Co. Ltd. - Segment focus
  • 12.9 Eli Lilly and Co.
  • Exhibit 137: Eli Lilly and Co. - Overview
  • Exhibit 138: Eli Lilly and Co. - Product / Service
  • Exhibit 139: Eli Lilly and Co. - Key news
  • Exhibit 140: Eli Lilly and Co. - Key offerings
  • 12.10 Grifols SA
  • Exhibit 141: Grifols SA - Overview
  • Exhibit 142: Grifols SA - Business segments
  • Exhibit 143: Grifols SA - Key offerings
  • Exhibit 144: Grifols SA - Segment focus
  • 12.11 H Lundbeck AS
  • Exhibit 145: H Lundbeck AS - Overview
  • Exhibit 146: H Lundbeck AS - Product / Service
  • Exhibit 147: H Lundbeck AS - Key offerings
  • 12.12 Johnson and Johnson
  • Exhibit 148: Johnson and Johnson - Overview
  • Exhibit 149: Johnson and Johnson - Business segments
  • Exhibit 150: Johnson and Johnson - Key news
  • Exhibit 151: Johnson and Johnson - Key offerings
  • Exhibit 152: Johnson and Johnson - Segment focus
  • 12.13 Lupin Ltd.
  • Exhibit 153: Lupin Ltd. - Overview
  • Exhibit 154: Lupin Ltd. - Product / Service
  • Exhibit 155: Lupin Ltd. - Key news
  • Exhibit 156: Lupin Ltd. - Key offerings
  • 12.14 Novartis AG
  • Exhibit 157: Novartis AG - Overview
  • Exhibit 158: Novartis AG - Business segments
  • Exhibit 159: Novartis AG - Key offerings
  • Exhibit 160: Novartis AG - Segment focus
  • 12.15 Pfizer Inc.
  • Exhibit 161: Pfizer Inc. - Overview
  • Exhibit 162: Pfizer Inc. - Product / Service
  • Exhibit 163: Pfizer Inc. - Key news
  • Exhibit 164: Pfizer Inc. - Key offerings
  • 12.16 Solco Healthcare
  • Exhibit 165: Solco Healthcare - Overview
  • Exhibit 166: Solco Healthcare - Key offerings
  • 12.17 Teva Pharmaceutical Industries Ltd.
  • Exhibit 167: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 168: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 171: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 172: Inclusions checklist
  • Exhibit 173: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 174: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 175: Research methodology
  • Exhibit 176: Validation techniques employed for market sizing
  • Exhibit 177: Information sources
  • 13.5 List of abbreviations
  • Exhibit 178: List of abbreviations
Product Code: IRTNTR40742

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global alzheimers disease therapeutics market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Drug class Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on E-commerce pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on E-commerce pharmacy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Distribution Channel ($ billion)
  • Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
  • Exhibits48: Chart on Drug Class - Market share 2023-2028 (%)
  • Exhibits49: Data Table on Drug Class - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by Drug Class
  • Exhibits51: Data Table on Comparison by Drug Class
  • Exhibits52: Chart on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by Drug Class ($ billion)
  • Exhibits65: Data Table on Market opportunity by Drug Class ($ billion)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: AB Science SA - Overview
  • Exhibits116: AB Science SA - Product / Service
  • Exhibits117: AB Science SA - Key offerings
  • Exhibits118: AbbVie Inc. - Overview
  • Exhibits119: AbbVie Inc. - Product / Service
  • Exhibits120: AbbVie Inc. - Key news
  • Exhibits121: AbbVie Inc. - Key offerings
  • Exhibits122: AgeneBio Inc. - Overview
  • Exhibits123: AgeneBio Inc. - Product / Service
  • Exhibits124: AgeneBio Inc. - Key offerings
  • Exhibits125: Aurobindo Pharma Ltd. - Overview
  • Exhibits126: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits127: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits128: Cipla Ltd. - Overview
  • Exhibits129: Cipla Ltd. - Business segments
  • Exhibits130: Cipla Ltd. - Key news
  • Exhibits131: Cipla Ltd. - Key offerings
  • Exhibits132: Cipla Ltd. - Segment focus
  • Exhibits133: Eisai Co. Ltd. - Overview
  • Exhibits134: Eisai Co. Ltd. - Business segments
  • Exhibits135: Eisai Co. Ltd. - Key offerings
  • Exhibits136: Eisai Co. Ltd. - Segment focus
  • Exhibits137: Eli Lilly and Co. - Overview
  • Exhibits138: Eli Lilly and Co. - Product / Service
  • Exhibits139: Eli Lilly and Co. - Key news
  • Exhibits140: Eli Lilly and Co. - Key offerings
  • Exhibits141: Grifols SA - Overview
  • Exhibits142: Grifols SA - Business segments
  • Exhibits143: Grifols SA - Key offerings
  • Exhibits144: Grifols SA - Segment focus
  • Exhibits145: H Lundbeck AS - Overview
  • Exhibits146: H Lundbeck AS - Product / Service
  • Exhibits147: H Lundbeck AS - Key offerings
  • Exhibits148: Johnson and Johnson - Overview
  • Exhibits149: Johnson and Johnson - Business segments
  • Exhibits150: Johnson and Johnson - Key news
  • Exhibits151: Johnson and Johnson - Key offerings
  • Exhibits152: Johnson and Johnson - Segment focus
  • Exhibits153: Lupin Ltd. - Overview
  • Exhibits154: Lupin Ltd. - Product / Service
  • Exhibits155: Lupin Ltd. - Key news
  • Exhibits156: Lupin Ltd. - Key offerings
  • Exhibits157: Novartis AG - Overview
  • Exhibits158: Novartis AG - Business segments
  • Exhibits159: Novartis AG - Key offerings
  • Exhibits160: Novartis AG - Segment focus
  • Exhibits161: Pfizer Inc. - Overview
  • Exhibits162: Pfizer Inc. - Product / Service
  • Exhibits163: Pfizer Inc. - Key news
  • Exhibits164: Pfizer Inc. - Key offerings
  • Exhibits165: Solco Healthcare - Overview
  • Exhibits166: Solco Healthcare - Key offerings
  • Exhibits167: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits168: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits169: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits170: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits171: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits172: Inclusions checklist
  • Exhibits173: Exclusions checklist
  • Exhibits174: Currency conversion rates for US$
  • Exhibits175: Research methodology
  • Exhibits176: Validation techniques employed for market sizing
  • Exhibits177: Information sources
  • Exhibits178: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!